Gemma L. Baillie

2.5k citations

19 papers · 1.8k · 1 hit paper · h-index 13

Impact in

Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in

Pharmacology 16
- Cannabis and Cannabinoid Research 15
- Cholinesterase and Neurodegenerative Diseases 1
Molecular Biology 11
- Pharmacological Receptor Mechanisms and Effects 6
- Receptor Mechanisms and Signaling 3

Co-authors: Ruth A. Ross (15 shared papers)Roger G. Pertwee (6 shared papers)Adèle Thomas (3 shared papers)Raj K. Razdan (1 shared paper)Angela M. Phillips (1 shared paper)Lesley Stevenson (2 shared papers)Iain R. Greig (4 shared papers)Matteo Zanda (6 shared papers)
Journals: RSC Advances (2 papers)Molecular Pharmacology (2 papers)Journal of Biological Chemistry (2 papers)British Journal of Pharmacology (2 papers)SLAS DISCOVERY (1 paper)
Partner nations: United Kingdom Canada United States

In The Last Decade

Gemma L. Baillie

19 papers receiving 1.7k citations

Gemma L. Baillie's Hit Papers

align trajectories log scale

Cannabidiol displays unexpectedly high potency as an antagonist of CB₁and CB₂receptor agonistsin vitro 2007 · 621 citations

Peers

Countries citing papers authored by Gemma L. Baillie

Since Specialization

Citations

This map shows the geographic impact of Gemma L. Baillie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma L. Baillie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma L. Baillie more than expected).

Fields of papers citing papers by Gemma L. Baillie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma L. Baillie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma L. Baillie. The network helps show where Gemma L. Baillie may publish in the future.

Co-authors

The 25 scholars most cited alongside Gemma L. Baillie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gemma L. Baillie Line = papers co-authored together Gemma L. Baillie links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Cannabidiol displays unexpectedly high potency as an antagonist of CB₁and CB₂receptor agonistsin vitro British Journal of Pharmacology ·Adèle Thomas, Gemma L. Baillie, Angela M. Phillips, Raj K. Razdan, Ruth A. Ross, Roger G. Pertwee Hit paper breakdown →	2007	621
2	Allosteric Modulation of the Cannabinoid CB1 Receptor Molecular Pharmacology ·M. R. Price, Gemma L. Baillie, Adèle Thomas, Lesley Stevenson, Morag Easson, Richard Goodwin, Adèle McLean, Lorraine McIntosh, Gillian Goodwin, Glenn Walker, Paul Westwood, Julia Marrs, Fiona Thomson, Phillip M. Cowley, Arthur Christopoulos, Roger G. Pertwee, Ruth A. Ross	2005	348
3	Evidence that the plant cannabinoid Δ⁹‐tetrahydrocannabivarin is a cannabinoid CB₁and CB₂receptor antagonist British Journal of Pharmacology ·Adèle Thomas, Lesley Stevenson, Kerrie N Wease, M. R. Price, Gemma L. Baillie, Ruth A. Ross, Roger G. Pertwee	2005	147
4	A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects Neuropsychopharmacology ·Bogna M. Ignatowska‐Jankowska, Gemma L. Baillie, Steven G. Kinsey, Molly S. Crowe, Sudeshna Ghosh, Robert A. Owens, Imad Damaj, Justin L. Poklis, Jenny L. Wiley, Matteo Zanda, Chiara Zanato, Iain R. Greig, Aron H. Lichtman, Ruth A. Ross	2015	138
5	Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids Journal of Biological Chemistry ·Sharon Anavi‐Goffer, Gemma L. Baillie, Andrew J. Irving, Jürg Gertsch, Iain R. Greig, Roger G. Pertwee, Ruth A. Ross	2011	129
6	CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity Molecular Pharmacology ·Gemma L. Baillie, James G. Horswill, Sharon Anavi‐Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean D. McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee, Ruth A. Ross	2012	98
7	Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor Journal of Biological Chemistry ·Derek M. Shore, Gemma L. Baillie, Dow P. Hurst, Frank Navas, Herbert H. Seltzman, Jahan P. Marcu, Mary E. Abood, Ruth A. Ross, Patricia H. Reggio	2013	62
8	The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB₁ Receptor Positive Allosteric Modulators Journal of Medicinal Chemistry ·Chih‐Chung Tseng, Gemma L. Baillie, Giulia Donvito, Mohammed Ahmed Mustafa, Sophie E. Juola, Chiara Zanato, Chiara Massarenti, Sergio Dall’Angelo, William T. A. Harrison, Aron H. Lichtman, Ruth A. Ross, Matteo Zanda, Iain R. Greig	2019	59
9	The pentafluorosulfanyl group in cannabinoid receptor ligands: synthesis and comparison with trifluoromethyl and tert-butyl analogues RSC Advances ·Stefano Altomonte, Gemma L. Baillie, Ruth A. Ross, Jennifer Riley, Matteo Zanda	2014	51
10	Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators Bioorganic & Medicinal Chemistry Letters ·Iain R. Greig, Gemma L. Baillie, Mostafa Abdelrahman, Laurent Trembleau, Ruth A. Ross	2016	21
11	In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer’s Disease SLAS DISCOVERY ·Laura Aitken, Gemma L. Baillie, Andrew Pannifer, Angus J. Morrison, Philip S. Jones, Terry Smith, Stuart P. McElroy, Frank J. Gunn‐Moore	2017	16
12	Phosphorylation of ezrin on Thr567 is required for the synergistic activation of cell spreading by EPAC1 and protein kinase A in HEK293T cells Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Euan Parnell, Andreas Koschinski, Manuela Zaccolo, Ryan T. Cameron, George S. Baillie, Gemma L. Baillie, Alison Porter, Stuart P. McElroy, Stephen J. Yarwood	2015	15
13	Synthesis and Structure‐Activity Relationships of N ‐(4‐Benzamidino)‐Oxazolidinones: Potent and Selective Inhibitors of Kallikrein‐Related Peptidase 6 ChemMedChem ·Elena De Vita, Niels Smits, Helma van den Hurk, Elizabeth Beck, Joanne F. M. Hewitt, Gemma L. Baillie, Emily Russell, Andrew Pannifer, Véronique Hamon, Angus J. Morrison, Stuart P. McElroy, Philip S. Jones, Natalia A. Ignatenko, Nikolas Gunkel, Aubry K. Miller	2019	14
14	The F238L Point Mutation in the Cannabinoid Type 1 Receptor Enhances Basal Endocytosis via Lipid Rafts Frontiers in Molecular Neuroscience ·Melanie Wickert, Keri L. Hildick, Gemma L. Baillie, Ruth Jelinek, Alejandro Aparisi Rey, Krisztina Monory, Miriam Schneider, Ruth A. Ross, Jeremy M. Henley, Beat Lutz	2018	12
15	A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives European Journal of Medicinal Chemistry ·Paolo Lazzari, Rita Distinto, Ilaria Manca, Gemma L. Baillie, Gabriele Murineddu, Marilena Pira, Matteo Falzoi, Monica Sani, Paula Morales, Ruth A. Ross, Matteo Zanda, Nadine Jagerovic, Gérard A. Pinna	2016	11
16	4-Cyano-5-(2-thiophenyl)-pyrazoles are high affinity CB₁receptor ligands RSC Advances ·Stefano Altomonte, Gemma L. Baillie, Ruth A. Ross, Matteo Zanda	2015	8
17	The Discovery of New Inhibitors of Insulin-Regulated Aminopeptidase by a High-Throughput Screening of 400,000 Drug-like Compounds International Journal of Molecular Sciences ·Johan Gising, Saman Honarnejad, Maaike Bras, Gemma L. Baillie, Stuart P. McElroy, Philip S. Jones, Angus J. Morrison, Julia Beveridge, Mathias Hallberg, Mats Larhed	2024	7
18	Pyrazole-type cannabinoid ligands conjugated with fluoro-deoxy-carbohydrates as potential PET-imaging agents: Synthesis and CB1/CB2 receptor affinity evaluation Journal of Fluorine Chemistry ·Simona Frau, Sergio Dall’Angelo, Gemma L. Baillie, Ruth A. Ross, Marilena Pira, Chih‐Chung Tseng, Paolo Lazzari, Matteo Zanda	2013	7
19	Allosteric Modulation of Cannabinoid CB ₁ Receptor The FASEB Journal ·Ruth A. Ross, Gemma L. Baillie, Roger G. Pertwee	2012	2

About Gemma L. Baillie

Gemma L. Baillie is a scholar working on Pharmacology, Molecular Biology, Cellular and Molecular Neuroscience, Surgery and Oncology, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Pharmacological Receptor Mechanisms and Effects (6 papers), Pancreatic function and diabetes (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Receptor Mechanisms and Signaling (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Pharmacology (1.4k citations), Cellular and Molecular Neuroscience (892 citations), Toxicology (81 citations), Pharmaceutical Science (73 citations) and Cognitive Neuroscience (229 citations). Gemma L. Baillie has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Ruth A. Ross, Roger G. Pertwee, Adèle Thomas, Raj K. Razdan, Angela M. Phillips, Lesley Stevenson, Iain R. Greig, Matteo Zanda, Sharon Anavi‐Goffer and Arthur Christopoulos. Their work appears in journals such as RSC Advances, Molecular Pharmacology, Journal of Biological Chemistry, British Journal of Pharmacology and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Gemma L. Baillie

Impact in

Papers in i

In The Last Decade

Gemma L. Baillie

Gemma L. Baillie's Hit Papers

Peers

Countries citing papers authored by Gemma L. Baillie

Fields of papers citing papers by Gemma L. Baillie

All Works

About Gemma L. Baillie

Explore authors with similar magnitude of impact

Papers in